Introduction: About 10 million people have low back pain (LBP) disability in Brazil, and several therapies are used to treat this condition, such as kinesiotherapy, manual therapy (MT) and photobiomodulation-PBM. Although studies have investigated the use of these methods in LBP, research seeking to evaluate the efficacy of the association between techniques is still needed. Objective: To evaluate the activation of the muscles lumbar region with the influence of PBM and MT associated with kinesiotherapy in the treatment of LBP. Methods: Twenty individuals with chronic LBP were randomly divided into two groups. The first group (MT) received vertebral mobilization associated with a kinesiotherapy exercise program, while the second group (830nm-PBM) received PBM associated with the exercise program, twice a week for 8 weeks. It was performed an evaluation of pain perceived by the visual analogic scale (VAS), lumbar disability by the Oswestry questionnaire, muscle strength by strain gauge and activation through surface electromyography, before and after the treatment protocol. EMG data analysis was performed by MatLab® software. The ANOVA two-way test was used (degree of significance p≤0.05), and the effects size by Hedge test. Results: Considering pain, the two groups presented a significant result (p<0.05). In muscle activation only the multifidus obtained different during side bridge (p<0.05) when compared intragroups. But none of the variables were different when evaluating intergroups. Conclusion: Both MT and PBM associated with kinesiotherapy for 8 weeks are effective in reducing pain, improving motor control and stability of the lumbar spine in patients with chronic LBP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.